FUD transiently decreased IOP in mice injected with Ad5-TGFβ2 viral vector. by Jennifer A. Faralli (4907311)

“…(B) IOPs were monitored for 5 more days (until Day 22) in a subset of mice from A. …”

H& E staining investigation of CAM treated with native-orientin (5 μM), native-orientin (10 μM), NF-O (5 μM), and NF-O (10 μM). by Yashwanth Elumalai (21743452)

Effects of Cu (5 µM) pretreatment on Hcy-induced decrease in cell viability and LDH release. by Daoyin Dong (424519)

eIF5a is up-regulated in unruptured AAAs and decreased in ruptured AAAs. by Dong Ma (584680)

Subjects:

An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy by A. N. Balandina (6729380)

Microinjection solution (200 µM bicuculline+10 µM SR101) concentration decreases with distance and does not directly affect contralateral cortex. by Jeffrey Walker (331808)

Reversion to susceptibility was consistent with decreasing relative <i>vanA</i> copy number. by Samuel E. Blechman (19506884)

SDG decreases p70S6K1 and increases AMPK protein expression in iron treated H9c2 cells. by Stephanie Puukila (568109)

WNF decreases Aβ peptides generation in HEK293 and SH-SY5Y human cells. by Htut Htut Htoo (3686641)

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)

Fuzzy partitions with decreasing fuzziness (μ values) are visualized as membership matrices. by Philip Wadewitz (730418)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

Decrease of dermal markers after <i>Wnt11</i> RNAi. by Gabriela Morosan-Puopolo (211008)

GL 5’Sμ mutations are greatly decreased in <i>aid</i>^<i>-/-</i> cells induced to switch to IgG3 and expressing AID C terminus mutations. by Tatenda Kadungure (782562)

GFP activity is decreased in DES. by Céline Portal (3876436)

“…<p><b>(a)</b> Scatterplots show that CGC number determined on histological sections (AB—PAS coloration), and GFP⁺ (Muc5b) and Muc5ac⁺ CGC number determined by immunofluorescence staining (anti-GFP and anti-Muc5ac antibody) decreased (n = 10 mice, 1 section per mouse, one symbol/mouse) after 10 days of BAK application (filled-in symbols) in one eye (PBS in the other, white-filled symbols) followed by 4 days without any treatment. …”

Schematic diagram of the track and latch comparator (a) conventional track and latch comparator (b) small signal model of the comparator. by Labonnah Farzana Rahman (641767)

Decreased expression of SMAD1/5/8 and VEFG in the Botox injected side MCC and subchondral bone. by Eliane H. Dutra (3207312)

Sample cases of each type of visual field defect. by Kyoung Min Lee (677987)

Subjects:

Scatter plot according to the type of ODD. by Kyoung Min Lee (677987)

Subjects: